期刊文献+

老年糖尿病患者急性心力衰竭血浆脂联素浓度变化及临床意义 被引量:3

Clinical significance and the changes of plasma adiponectin in old diabetes patients with acute heart failure
原文传递
导出
摘要 目的研究老年糖尿病患者急性心力衰竭(AHF)时血浆脂联素(APN)浓度变化及临床意义。方法 135例观察对象,根据有无急性心力衰竭及糖尿病分为4组:非糖尿病心力衰竭组(A组)31例;糖尿病心力衰竭组(B组)43例,非糖尿病对照组(C组)30例,糖尿病对照组(D组)31例。入院即刻检测APN、NTproBNP,并行超声心动图检查,记录缓解时间及随访30d心血管事件发生情况,分析各组之间的差异及各指标间的相关性。结果 (1)AHF时,B组肺部啰音≥50%的患者发生率,下肢水肿发生比例、LgNTproBNP、治疗时间>24h比例、30d内心血管事件发生率明显高于A组(P<0.05);心脏射血分数(EF)值明显降低(P<0.01)。(2)A组、B组、C组、D组APN浓度分别为:(21.27±4.36)μg/L,(18.31±4.17)μg/L,(14.27±2.54)μg/L,(11.49±1.09)μg/L,各组间差异有统计学意义。(3)B组APN>18.31μg/L的患者中有66.7%治疗时间>24h,30d心血管事件发生率为61.5%。(4)AHF患者APN浓度与LgNTproBNP呈正相关(A组r=0.693,B组r=0.575,P均<0.01)。结论 (1)合并糖尿病的老年AHF患者心力衰竭程度重、治疗反应差,死亡率高,30d内心血管事件多发。(2)AHF患者血浆APN浓度明显升高,糖尿病患者APN代偿性升高能力受到抑制。 Objective To study the clinical significance and the changes of plasma adiponectin(APN)concentrations in old patients with diabetes during acute heart failure(AHF).Methods 135 patients were divided into four groups by history of AHF and diabetes mellitus (DM):AHF without DM (group A,n =31),AHF with DM(group B,n =43),Control group without DM(group C,n =30),Control group with DM(group D,n =31).APN,NTproBNP were analysed before treated and UCG were undertook in 24 h.Record the time of remission.A 30-day follow-up by phone to verify cardiovascular events.Analysis the differences between the group and the relationship of the data.Results (1) The range of moistrale,incidence of lower-extremity edema,NTproBNP in group Bsignificantly higher than group A (P 〈 0.05).Time of remission in group B were longer,30-day cardiac events was higher than group A (P 〈 0.05).(2) APN of group A,B,C,D were significantly different [(21.27 ± 4.36) μg/L,(18.31 ± 4.17) μg/L,(14.27 ± 2.54) μg/L,(11.49 ± 1.09) ag/L,respectively,P 〈 0.01].(3) In group B,66.7% patients with APN 〉 18.31 μg/L stay in hospital longer than 24 h,the incidence of 30-day cardiovascular events higher(P 〈 0.01).(4) Plasma APN concentration was positively correlated with LgNTproBNP (r =0.693,0.575,P 〈 0.01).Conclusions (1) In old AHF patients with DM,heart failure degree were heavier,combined with poor therapy effect,high-mortality,and high incidence of 30-day cardiovascular events.(2) APN level elevated with the degree of AHF.In patients with DM,ability of compensatory increase in APN were weaken.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第1期35-38,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 心力衰竭 糖尿病 脂联素 Heart failure Diabetes mellitus Adiponectin
  • 相关文献

参考文献10

  • 1P Herrero,LR Peterson,JB McGill.Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus[].Journal of the American College of Cardiology.2006
  • 2Ding G,Qin Q,He N,Francis-David SC,Hou J,Liu J,Ricks E,Yang Q.Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma[].Journal of Molecular and Cellular Cardiology.2007
  • 3Goldstein BJ,Scalia RG,Ma XL.Protective vascular and myocardial effects of adiponectin[].Nat Clin Pract Cardiovasc Med.2009
  • 4Cesari M,Rossi GP.Adiponectin and prognostic outcome in patients with coronary artery disese[].European Heart Journal.2008
  • 5Masson S,Gori F,Latini R,et al.Adiponectin in chronic heartfailure:influence of diabetes and genetic variants[].European Journal of Clinical Investigation.2011
  • 6Yamaji M,Tsutamoto T,Tanaka T,et al.Effect of carperitide onplasma adiponectin levels in acute decompensated heart failurepatients with diabetes mellitus[].Circulation Journal.2009
  • 7Motoshima H,Wu X,Mahadev K,et al.Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL[].Biochemical and Biophysical Research Communications.2004
  • 8Tan KC,Xu A,Chow WS,et al.Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation[].The Journal of Clinical Endocrinology.2004
  • 9Capes S E,Hunt D,Malmberg K,et al.Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview[].The Lancet.2000
  • 10Hug C,Wang J,Ahmad NS,et al.T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin[].Proceedings of the National Academy of Sciences of the United States of America.2004

同被引文献11

引证文献3

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部